Browsing by Author "Debus, J."
Now showing 1 - 20 of 62
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settingsA dosimetric comparison: Intensity Modulated Proton Therapy (IMPT), Volumetric Modulated Arc Therapy (VMAT) and Three-Dimensional Conformal Radiotherapy (3D-CRT) for anaplastic astrocytoma and glioblastoma(2016)
;Adeberg, Sebastian ;Harrabi, Semi ;Bougatf, Nina ;Tonndorf-Martini, Eric ;Bernhardt, Denise ;Rieber, J. ;Koerber, Stefan ;Mohr, A. ;Haberer, Thomas ;Herfarth, K. ;Debus, J. - Some of the metrics are blocked by yourconsent settingsA Transcriptional Fingerprint of Carbon Ion Radiotherapy in Patients with Recurrent Glioma Utilizing Peripheral Blood as a Sentinel Organ(2019)
;Waltenberger, M. ;Knoll, M. ;Schlegel, J. ;Wirkner, U. ;Schwager, C. ;Bernhardt, D. ;Adeberg, S.; ;Combs, S. E. ;Herold-Mende, C. ;Debus, J.Abdollahi, A. - Some of the metrics are blocked by yourconsent settingsAlkylans after alkylans: therapy results after the use of ACNU in progressive glioblastoma after primary combined radiochemotherapy as well as adjuvant chemotherapy with temozolomide(2009)
;Mohr, A.; ;Welzel, Thomas ;Debus, J.Combs, Stephanie - Some of the metrics are blocked by yourconsent settingsAn intraindividual comparison of target volume definition for radiation therapy based on contrast-enhanced MRI, -O-(2-[18F]-fluoroethyl)-L-tyrosine (FET)- and [68Ga]-DOTA-D Phe 1-3Tyr3-Octreotide (DOTATOC)-PET in 21 patients with meningiomas - final results(2013)
;Dittmar, J. ;Giesel, Frederik ;Kratochwill, K. ;Christmann, A. ;Welzel, Thomas ;Habermehl, Daniel; ;Haberkorn, Uwe ;Debus, J.Combs, Stephanie - Some of the metrics are blocked by yourconsent settingsCarbon Ion Irradiation With Or Without The Addition Of Cilengitide Is An Effective Inhibitor Of Integrine-Mediated Tumor Cell Migration(2010)
; ;Habermehl, Daniel ;Wurth, L. ;Mohr, A. ;Lindel, K. ;Weber, Klaus ;Haberer, Thomas ;Debus, J.Combs, Stephanie - Some of the metrics are blocked by yourconsent settingsCombination of photon and carbon ion irradiation with targeted therapy substances in hepatocellular carcinoma cell lines(2014)
;Dehne, S. ;Fritz, C. ;Baris, D. ;Orschiedt, L.; ;Dittmar, J. ;Brons, S. ;Haberer, Thomas ;Debus, J. ;Weber, Klaus ;Combs, StephanieHabermehl, Daniel - Some of the metrics are blocked by yourconsent settingsComparison of target volume definition for radiation therapy based on contrast-enhanced MRI, O-(2-(18F)-fluoroethyl)-L-tyrosine (FET)- and (68 Ga)-DOTA-D Phe 1-3Tyr3-Octreotide (DOTATOC)-PET in patients with meningiomas(2012)
;Dittmar, J. ;Giesel, Frederik ;Kratochwill, K. ;Christmann, A. ;Welzel, Thomas ;Habermehl, Daniel; ;Haberkorn, Uwe ;Debus, J.Combs, Stephanie - Some of the metrics are blocked by yourconsent settingsCorrelation of magnesium homeostasis under combined radiation chemo-immunotherapy with temozolomide with cetuximab and overall survival in patients with primary glioblastoma(2009)
; ;Mohr, A. ;Welzel, Thomas ;Milker-Zabel, S. ;Platten, M. ;Wick, Wolfgang ;Debus, J.Combs, Stephanie - Some of the metrics are blocked by yourconsent settingsDisrupting the mTOR pathway by mTORC1-or dual Pi3K/mTOR-inhibitors reduces cell survival and proliferation and enhances radio-sensitivity of primary meningioma cells irradiated by photons or carbon ions(2014)
;Dittmar, J. ;Ketter, Ralf ;Urbschat, Steffi ;Dittmar, A. ;Baris, D. ;Habermehl, Daniel; ;Oertel, Joachim ;Debus, J.Combs, Stephanie - Some of the metrics are blocked by yourconsent settingsEffect of Carbon Ion Irradiation on Human Papillomavirus (HPV) 16 Positive Cervical Keratinocytes(2011)
;Lindel, K.; ;Daffinger, S. ;Combs, S. ;Weber, K.J.Debus, J. - Some of the metrics are blocked by yourconsent settingsEffects of 12-week resistance training during radiotherapy in breast cancer patients(2017-11)
;Wiskemann, J. ;Schmidt, M. E.; ;Debus, J. ;Ulrich, C. M. ;Potthoff, K.Steindorf, K.Exercise is considered to be an effective supportive treatment approach in breast cancer (BC) patients. We conducted a randomized controlled trial to assess the efficacy of a 12-week PRT during radiotherapy. Strength performance was assessed by maximal isokinetic peak torque (MIPT) in two different angular velocities (60°/s and 180°/s) and maximal voluntary isometric contraction for shoulder external and internal rotation, as well as for knee extension and flexion were assessed pre- and post-intervention in 146 patients randomized to PRT or a control group. Statistical analyses were based on analysis of covariance models for the individual changes from baseline to week 13. Intention-to-treat analyses showed significant between-group differences favoring the exercise group (EX) for MIPT in knee flexion and shoulder internal and external rotation (P < 0.05). Subgroup analyses showed borderline significant differences with regard to pretreatment history, revealing that pretreated chemotherapy patients tend to benefit more from PRT than patients without chemotherapy (P = 0.06). Strength gain at the operated arm was significantly higher than at the non-operated arm in EX. PRT was efficacious in increasing upper and lower limb strength in BC patients undergoing adjuvant radiotherapy. Patients with restrictions due to breast cancer-related surgery and pretreated with chemotherapy might benefit the most. - Some of the metrics are blocked by yourconsent settingsEP-1090: Particle therapy and IMRT for patients with esthesioneuroblastoma: a single-institution experience(2017)
;Liermann, J. ;Syed, M. ;Bernhardt, D. ;Bougatf, N. ;Harrabi, S.B. ;Paul, A. ;Sprave, T.; ;Haberer, T. ;Herfarth, K. ;Debus, J. ;Hauswald, H.Adeberg, S. - Some of the metrics are blocked by yourconsent settingsEP-1117: Sequential Proton Boost after Standard Chemoradiation for High-Grade Glioma(2017)
;Adeberg, S. ;Bernhardt, D. ;Harrabi, S. ;Uhl, M. ;Paul, A. ;Bougatf, N. ;Verma, V. ;Haberer, T. ;Combs, S. ;Herfarth, K. ;Debus, J. - Some of the metrics are blocked by yourconsent settingsEP-1125: Concomitant temozolomide therapy improves survival outcome of patients with multifocal glioblastoma(2017)
;Syed, M. ;Liermann, J. ;Sprave, T. ;Verma, V. ;Rieber, J. ;Harrabi, S.B. ;Bougatf, N. ;Bernhardt, D. ;Mohr, A.; ;Debus, J.Adeberg, S. - Some of the metrics are blocked by yourconsent settingsEP-1155 Rare entities in head-and-neck cancer: A single institutional experience of carbon-ion reirradiation(2019)
;Held, T. ;Windisch, P. ;Akbaba, S. ;Lang, K. ;Bernhardt, D. ;Plinkert, P. ;Kargus, S. ;Freier, K.; ;Herfarth, K. ;Debus, J.Adeberg, S. - Some of the metrics are blocked by yourconsent settingsEP-1207: Outcomes and prognostic factors in solitary brain metastasis from small cell lung cancer(2017)
;Bernhardt, D. ;Adeberg, S. ;Bozorgmehr, F. ;Kappes, J. ;Hoerner-Rieber, J. ;Koenig, L. ;Debus, J. ;Thomas, M. ;Unterberg, A. ;Herth, F. ;Heussel, C.P. ;Steins, M. - Some of the metrics are blocked by yourconsent settingsEP-1212: Parenchymal and functional lung changes after stereotactic body radiotherapy for early-stage NSCLC(2017)
;Rieber, J. ;Dern, J. ;Bernhardt, D. ;König, L. ;Adeberg, S. ;Paul, A. ;Kappes, J. ;Hoffmann, H. ;Debus, J. ;Heussel, C.P. - Some of the metrics are blocked by yourconsent settingsEP-1215 Fibroblast Activating Protein specific PET for advanced target volume delineation in Glioblastoma(2019)
;Windisch, P. ;Röhrich, M. ;Regnery, S. ;Tonndorf-Martini, E. ;Held, T. ;Lang, K. ;Bernhardt, D.; ;Haberkorn, U. ;Debus, J.Adeberg, S. - Some of the metrics are blocked by yourconsent settingsEP-1219: Dosimetric Comparison of Proton RT with Standard of Care Photon RT Techniques in CNS Tumors(2018)
;Adeberg, S. ;Harrabi, S. ;Bougatf, N. ;Verma, V. ;Bernhardt, D. ;Combs, S. ;Haberer, T. ;Herfarth, K. ;Debus, J. - Some of the metrics are blocked by yourconsent settingsEP-1331: Diabetes and metformin influence survival in glioblastoma patients(2015)
;Adeberg, S. ;Kehle, D. ;Mohr, A.; ;Bostel, T. ;Koelsche, C. ;Diehl, C.Debus, J.